All Stories

  1. Exploring Machine Learning for Untargeted Metabolomics Using Molecular Fingerprints
  2. CD99 Expression and Prognostic Impact in Glioblastoma: A Single-Center Cohort Study
  3. A synthetic thiol molecule releasing N-acetyl-l-cysteine and cysteamine drives early up-regulation of immunoproteasome subunits in the lymph nodes of mice infected with LP-BM5 leukemia retrovirus
  4. Drug transport by red blood cells
  5. Rapid monitoring of SARS-CoV-2 variants of concern through high-resolution melt analysis
  6. Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages
  7. KRAS4A and KRAS4B in liquid biopsy of metastatic lung adenocarcinoma patients treated with Pembrolizumab or chemotherapy plus Pembrolizumab
  8. Compatibility of Nucleobases Containing Pt(II) Complexes with Red Blood Cells for Possible Drug Delivery Applications
  9. Assessment of a new UV-C light-emitting diode–based technology for air sanitization in indoor sports environments
  10. Comparing Heterologous and Homologous COVID-19 Vaccination: A Longitudinal Study of Antibody Decay
  11. Sirtuin 6 Regulates the Activation of the ATP/Purinergic Axis in Endothelial Cells
  12. Clonal Spread of Hospital-Acquired NDM-1-Producing Klebsiella pneumoniae and Escherichia coli in an Italian Neonatal Surgery Unit: A Retrospective Study
  13. Anoxia Rapidly Induces Changes in Expression of a Large and Diverse Set of Genes in Endothelial Cells
  14. Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs
  15. AFM evaluation of a humanized recombinant antibody affecting C. auris cell wall and stability
  16. Targeting SARS‐CoV ‐2 by synthetic dual‐acting thiol compounds that inhibit Spike/ ACE2 interaction and viral protein production
  17. New human ATM variants are able to regain ATM functions in ataxia telangiectasia disease
  18. Development and in vitro characterization of a humanized scFv against fungal infections
  19. Functionalized 3D scaffolds for engineering the hematopoietic niche
  20. The host micro-RNA cfa-miR-346 is induced in canine leishmaniasis
  21. Engineering new metabolic pathways in isolated cells for the degradation of guanidinoacetic acid and simultaneous production of creatine
  22. SARS-CoV-2 RNA Detection on Environmental Surfaces in a University Setting of Central Italy
  23. Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral Treatment
  24. CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML
  25. Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
  26. Prevalence and Molecular Typing of Carbapenemase-Producing Enterobacterales among Newborn Patients in Italy
  27. External quality assessment of HIV-1 DNA quantification assays used in the clinical setting in Italy
  28. Airborne Microorganism Inactivation by a UV-C LED and Ionizer-Based Continuous Sanitation Air (CSA) System in Train Environments
  29. Influenza Virus Down-Modulates G6PD Expression and Activity to Induce Oxidative Stress and Promote Its Replication
  30. Multitalented Synthetic Antimicrobial Peptides and Their Antibacterial, Antifungal and Antiviral Mechanisms
  31. SPIO nanoparticles and magnetic erythrocytes as contrast agents for biomedical and diagnostic applications
  32. Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS–FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 Activity
  33. Phenotype Screening of an Azole-bisindole Chemical Library Identifies URB1483 as a New Antileishmanial Agent Devoid of Toxicity on Human Cells
  34. Gastrointestinal Tumors: Phytochemical and Drug Combinations Targeting the Hallmarks of Cancer
  35. Functional Classification of the ATM Variant c.7157C>A and In Vitro Effects of Dexamethasone
  36. A new humanized antibody is effective against pathogenic fungi in vitro
  37. Meet the Editorial Board Member
  38. Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma
  39. Intellectual Disability and Brain Creatine Deficit: Phenotyping of the Genetic Mouse Model for GAMT Deficiency
  40. Cohort Analysis of 67 Charcot-Marie-Tooth Italian Patients: Identification of New Mutations and Broadening of Phenotype Expression Produced by Rare Variants
  41. In Vitro Reduced Susceptibility to Pentavalent Antimonials of a Leishmania infantum Isolate from a Human Cutaneous Leishmaniasis Case in Central Italy
  42. Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib
  43. The nucleoplasmic interactions among Lamin A/C-pRB-LAP2α-E2F1 are modulated by dexamethasone
  44. Intracellular Redox-Modulated Pathways as Targets for Effective Approaches in the Treatment of Viral Infection
  45. Human Red Blood Cells Modulate Cytokine Expression in Monocytes/Macrophages Under Anoxic Conditions
  46. Activation of NRF2 and ATF4 Signaling by the Pro-Glutathione Molecule I-152, a Co-Drug of N-Acetyl-Cysteine and Cysteamine
  47. Carriage of Carbapenem-Resistant Enterobacterales in Adult Patients Admitted to a University Hospital in Italy
  48. Transcriptomic profile of ataxia telangiectasia cells treated for 30 days with a low dose of dexamethasone
  49. Preclinical developments of enzyme-loaded red blood cells
  50. Evaluation of a kDNA-Based qPCR Assay for the Detection and Quantification of Old World Leishmania Species
  51. I-152, a supplier of N-acetyl-cysteine and cysteamine, inhibits immunoglobulin secretion and plasma cell maturation in LP-BM5 murine leukemia retrovirus-infected mice by affecting the unfolded protein response
  52. Missense mutations in EDA and EDAR genes cause dominant syndromic tooth agenesis
  53. Redox homeostasis as a target for new antimycobacterial agents
  54. Efficient Cocaine Degradation by Cocaine Esterase-Loaded Red Blood Cells
  55. Basic and applied science at the time of COVID‐19
  56. Antiviral Properties of Flavonoids and Delivery Strategies
  57. The Ubiquitin Gene Expression Pattern and Sensitivity to UBB and UBC Knockdown Differentiate Primary 23132/87 and Metastatic MKN45 Gastric Cancer Cells
  58. Meet Our Editorial Board Member
  59. TP53 Mutation Analysis in Gastric Cancer and Clinical Outcomes of Patients with Metastatic Disease Treated with Ramucirumab/Paclitaxel or Standard Chemotherapy
  60. Redox-Modulating Agents in the Treatment of Viral Infections
  61. Differentiation of Leishmania (L.) infantum, Leishmania (L.) amazonensis and Leishmania (L.) mexicana Using Sequential qPCR Assays and High-Resolution Melt Analysis
  62. Plasmid Replicon Typing of Antibiotic-Resistant Escherichia coli From Clams and Marine Sediments
  63. A comparative analysis of unintegrated HIV-1 DNA measurement as a potential biomarker of the cellular reservoir in the blood of patients controlling and non-controlling viral replication
  64. In Ataxia-Telangiectasia, Oral Betamethasone Administration Ameliorates Lymphocytes Functionality through Modulation of the IL-7/IL-7Rα Axis Paralleling the Neurological Behavior: A Comparative Report of Two Cases
  65. Glycolytic competence in gastric adenocarcinomas negatively impacts survival outcomes of patients treated with salvage paclitaxel-ramucirumab
  66. Development of long circulating magnetic particle imaging tracers: use of novel magnetic nanoparticles and entrapment into human erythrocytes
  67. Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies
  68. Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  69. A Novel Homozygous Variant in the Fork-Head-Associated Domain of Polynucleotide Kinase Phosphatase in a Patient Affected by Late-Onset Ataxia With Oculomotor Apraxia Type 4
  70. Real-time PCR to differentiate among Leishmania (Viannia) subgenus, Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis: Application on Brazilian clinical samples
  71. DDIT4 gene expression is switched on by a new HDAC4 function in ataxia telangiectasia
  72. A negative feedback mechanism links UBC gene expression to ubiquitin levels by affecting RNA splicing rather than transcription
  73. Data on the differentiation among Leishmania (Viannia) spp., Leishmania (Leishmania) infantum and Leishmania (Leishmania) amazonensis in Brazilian clinical samples using real-time PCR
  74. Reduction of Immune Activation and Partial Recovery of Staphylococcal Enterotoxin B-Induced Cytokine Production After Switching to an Integrase Strand Transfer Inhibitor-Containing Regimen: Results from an Observational Cohort Study
  75. Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations
  76. Red Blood Cell Membrane Processing for Biomedical Applications
  77. Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
  78. Corrigendum: GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  79. XRCC1 399GG genotype predicts significantly longer overall survival in resistant lymphoma patients treated with Benda-EAM and ASCT
  80. Boosting GSH Using the Co-Drug Approach: I-152, a Conjugate of N-acetyl-cysteine and β-mercaptoethylamine
  81. Secosterol-B affects endoplasmic reticulum structure in endothelial cells
  82. Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
  83. FKBP5 rs4713916: A Potential Genetic Predictor of Interindividual Different Response to Inhaled Corticosteroids in Patients with Chronic Obstructive Pulmonary Disease in a Real-Life Setting
  84. Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination
  85. Identification, Expression and Preliminary Characterization of a Recombinant Bifunctional Enzyme of Photobacterium damselae subsp. piscicida with Glutamate Decarboxylase/Transaminase Activity
  86. Glutathione increase by the n-butanoyl glutathione derivative (GSH-C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus
  87. Magnetic Manipulation of Blood Conductivity with Superparamagnetic Iron Oxide-Loaded Erythrocytes
  88. Biochemical Properties and Oxalate‐Degrading Activity of Oxalate Decarboxylase from Bacillus subtilis at Neutral pH
  89. Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study
  90. GSH-C4 Acts as Anti-inflammatory Drug in Different Models of Canonical and Cell Autonomous Inflammation Through NFκB Inhibition
  91. The Yin and Yang of Current Antifungal Therapeutic Strategies: How Can We Harness Our Natural Defenses?
  92. Evaluation of PCR-based methods for the identification of enteroaggregative hemorrhagic Escherichia coli in sprouts
  93. Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors
  94. Exploiting genetic polymorphisms in metabolic enzymes for rapid screening of Leishmania infantum genotypes
  95. Humanization of Antibodies using a Statistical Inference Approach
  96. Induction of ubiquitin C (UBC ) gene transcription is mediated by HSF1: role of proteotoxic and oxidative stress
  97. Preclinical evaluation of an innovative anti-TAM approach based on zoledronate-loaded erythrocytes
  98. Leishmania Infection Induces MicroRNA hsa-miR-346 in Human Cell Line-Derived Macrophages
  99. Real-time PCR applications for diagnosis of leishmaniasis
  100. A new therapy prevents intellectual disability in mouse with phenylketonuria
  101. Comparison of the Diatheva STEC FLUO with BAX System Kits for Detection of O157:H7 and Non-O157 Shiga Toxin-Producing Escherichia coli (STEC) in Ground Beef and Bean Sprout Samples Using Different Enrichment Protocols
  102. Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone
  103. Ferucarbotran-loaded red blood cells as long circulating MRI contrast agents: first in vivo results in mice
  104. Ataxia-telangiectasia
  105. Detection of Shiga toxin-producing Escherichia coli (STEC) in ground beef and bean sprouts: Evaluation of culture enrichment conditions
  106. MTHFR, TS and XRCC1 genetic variants may affect survival in patients with myelodysplastic syndromes treated with supportive care or azacitidine
  107. Endothelial cells, endoplasmic reticulum stress and oxysterols
  108. Control of the HIV-1 DNA Reservoir Is Associated In Vivo and In Vitro with NKp46/NKp30 (CD335 CD337) Inducibility and Interferon Gamma Production by Transcriptionally Unique NK Cells
  109. Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients
  110. Engineered red blood cells as therapeutic agents
  111. Endoplasmic reticulum stress and unfolded protein response in infection by intracellular parasites
  112. In vivo effects of dexamethasone on blood gene expression in ataxia telangiectasia
  113. ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T
  114. Validation and application of a quantitative real-time PCR assay to detect common wheat adulteration of durum wheat for pasta production
  115. The use of kDNA minicircle subclass relative abundance to differentiate between Leishmania (L.) infantum and Leishmania (L.) amazonensis
  116. Comparative analysis of the standard PCR-Based Replicon Typing (PBRT) with the commercial PBRT-KIT
  117. Determination of Interference DuringIn VitroPyrogen Detection: Development and Characterization of a Cell-Based Assay
  118. Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor
  119. Reengineering red blood cells for cellular therapeutics and diagnostics
  120. Intravascular contrast agents in diagnostic applications: Use of red blood cells to improve the lifespan and efficacy of blood pool contrast agents
  121. Glutathione and its derivatives for the treatment of microbial infections.
  122. Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment
  123. Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages
  124. Nano-Mechanical Characterization of Ataxia Telangiectasia Cells Treated with Dexamethasone
  125. Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution
  126. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents
  127. Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response
  128. Enterococcus faeciumST17 from Coastal Marine Sediment Carrying Transferable Multidrug Resistance Plasmids
  129. Gender effects of single nucleotide polymorphisms and miRNAs targeting clock-genes in metastatic colorectal cancer patients (mCRC)
  130. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial
  131. LP-BM5 infection and glutathione
  132. Erythrocyte-mediated delivery of recombinant enzymes
  133. Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
  134. Validation of a Reversed-Phase High Performance Liquid Chromatography Method for the Simultaneous Analysis of Cysteine and Reduced Glutathione in Mouse Organs
  135. Modulation of Stat-1 in Human Macrophages Infected with Different Species of Intracellular Pathogenic Bacteria
  136. Selection of Vaccine Candidates for Fish Pasteurellosis Using Reverse Vaccinology and an In Vitro Screening Approach
  137. Process development of a human recombinant diabody expressed in E. coli: engagement of CD99-induced apoptosis for target therapy in Ewing’s sarcoma
  138. Retrieving embryo genetic information from spent culture medium
  139. Dynamic transcription of ubiquitin genes under basal and stressful conditions and new insights into the multiple UBC transcript variants
  140. The Human Antibody Fragment DIATHIS1 Specific for CEACAM1 Enhances Natural Killer Cell Cytotoxicity Against Melanoma Cell Lines In Vitro
  141. Adherence and intracellular survival within human macrophages of Enterococcus faecalis isolates from coastal marine sediment
  142. Molecular Dissection of the Human Ubiquitin C Promoter Reveals Heat Shock Element Architectures with Activating and Repressive Functions
  143. Inhibition of Testosterone Aromatization by the Indole-3-carbinol Derivative CTet in CYP19A1-overexpressing MCF-7 Breast Cancer Cells
  144. Label-free quantification of Tacrolimus in biological samples by atomic force microscopy
  145. HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial
  146. Positive effect of erythrocyte-delivered dexamethasone in ataxia-telangiectasia
  147. Validation according to ISO/TS 12869:2012 of a molecular method for the isolation and quantification of Legionella spp. in water
  148. Selective protein detection with a dsLNA-functionalized nanopore
  149. Programmable 3D silk bone marrow niche for platelet generation ex vivo and modeling of megakaryopoiesis pathologies
  150. Anti influenza therapy
  151. Effect of starvation on survival and virulence expression of Aeromonas hydrophila from different sources
  152. CD99 Triggering in Ewing Sarcoma Delivers a Lethal Signal through p53 Pathway Reactivation and Cooperates with Doxorubicin
  153. Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients
  154. A Real Time PCR Platform for the Simultaneous Quantification of Total and Extrachromosomal HIV DNA Forms in Blood of HIV-1 Infected Patients
  155. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pahenu2 mice
  156. Application of qPCR in conjunctival swab samples for the evaluation of canine leishmaniasis in borderline cases or disease relapse and correlation with clinical parameters
  157. Red Blood Cells as Carriers of Iron Oxide-Based Contrast Agents for Diagnostic Applications
  158. Enhancing neutral lipid content in Skeletonema marinoi through multiple phase growth in a bench photobioreactor
  159. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: Design and characterization of the enzymatic properties
  160. Promoter-specific relevance of histone modifications induced by dexamethasone during the regulation of pro-inflammatory mediators
  161. Macrophage Depletion by Free Bisphosphonates and Zoledronate-Loaded Red Blood Cells
  162. Blocking monocyte transmigration in in vitro system by a human antibody scFv anti-CD99. Efficient large scale purification from periplasmic inclusion bodies in E. coli expression system
  163. Genetic modulation of the interleukin 6 (IL-6) system in patients with advanced gastric cancer: a background for an alternative target therapy
  164. Effect of the N-butanoyl glutathione (GSH) derivative and acyclovir on HSV-1 replication and Th1 cytokine expression in human macrophages
  165. Clinical impact of the HGF/MET pathway activation in patients with advanced gastric cancer treated with palliative chemotherapy
  166. Forward subtractive libraries containing genes transactivated by dexamethasone in ataxia-telangiectasia lymphoblastoid cells
  167. USPIO-loaded red blood cells as a biomimetic MR contrast agent: a relaxometric study
  168. An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas
  169. Approaches to erythrocyte-mediated drug delivery
  170. Detection and Characterization of Leishmania (Leishmania) and Leishmania (Viannia) by SYBR Green-Based Real-Time PCR and High Resolution Melt Analysis Targeting Kinetoplast Minicircle DNA
  171. Erythrocytes as Carriers for Drugs and Contrast Agents
  172. Intra-Erythrocyte Infusion of Dexamethasone Reduces Neurological Symptoms in Ataxia Teleangiectasia Patients: Results of a Phase 2 Trial
  173. Photobacteriosis: Prevention and Diagnosis
  174. Isolation of a new human scFv antibody recognizing a cell surface binding site to CEACAM1. Large yield production, purification and characterization in E. coli expression system
  175. New Strategies to Prolong the In Vivo Life Span of Iron-Based Contrast Agents for MRI
  176. Anti-inflammatory effect of ubiquinol-10 on young and senescent endothelial cells via miR-146a modulation
  177. Recent advances in synthesis, characterization of hydroxyapatite/polyurethane composites and study of their biocompatible properties
  178. Yin Yang 1 Intronic Binding Sequences and Splicing Elicit Intron-Mediated Enhancement of Ubiquitin C Gene Expression
  179. Genomic DNA in human blastocoele fluid
  180. Neutral Lipid Content and Biomass Production in Skeletonema marinoi (Bacillariophyceae) Culture in Response to Nitrate Limitation
  181. Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection
  182. Erythrocytes-mediated Delivery of Dexamethasone 21-phosphate in Steroid-dependent Ulcerative Colitis
  183. Magnetic red blood cells as new contrast agents for MRI applications
  184. Molecules Altering the Intracellular Thiol Content Modulate NF-kB and STAT-1/IRF-1 Signalling Pathways and IL-12 p40 and IL-27 p28 Production in Murine Macrophages
  185. Antitumoral Activity of Indole-3-carbinol Cyclic tri- and Tetrameric Derivatives Mixture in Human Breast Cancer Cells: In Vitro and In Vivo Studies
  186. Use of red blood cells as new strategy to avoid the rapid clearance of SPIOs nanoparticles
  187. Isolation of a novel gene from Photobacterium damselae subsp. piscicida and analysis of the recombinant antigen as promising vaccine candidate
  188. Red blood cells as carriers in magnetic particle imaging
  189. Deciphering the single-cell omic: innovative application for translational medicine
  190. CEACAM1 is a Privileged Cell Surface Antigen to Design Novel ScFv Mediated-Immunotherapies of Melanoma, Lung Cancer and Other Types of Tumors
  191. HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies
  192. Dexamethasone Partially Rescues Ataxia Telangiectasia-mutated (ATM) Deficiency in Ataxia Telangiectasia by Promoting a Shortened Protein Variant Retaining Kinase Activity
  193. Induction of Endoplasmic Reticulum Stress Response by the Indole-3-Carbinol Cyclic Tetrameric Derivative CTet in Human Breast Cancer Cell Lines
  194. Palytoxin and an Ostreopsis Toxin Extract Increase the Levels of mRNAs Encoding Inflammation-Related Proteins in Human Macrophages via p38 MAPK and NF-κB
  195. The expression and modulation of CEACAM1 and tumor cell transformation
  196. High Let-7a MicroRNA Levels in KRAS-Mutated Colorectal Carcinomas May Rescue Anti-EGFR Therapy Effects in Patients with Chemotherapy-Refractory Metastatic Disease
  197. Microbiological Surveillance of a Bovine Raw Milk Farm Through Multiplex Real-Time PCR
  198. Unique Toxin Profile of a Mediterranean Ostreopsis cf. ovata Strain: HR LC-MSn Characterization of Ovatoxin-f, a New Palytoxin Congener
  199. Development of a multilevel approach for the evaluation of nanomaterials’ toxicity
  200. Erythrocytes as a novel delivery vehicle for biologics: from enzymes to nucleic acid-based therapeutics
  201. Erythrocytes as carriers for drugs: the transition from the laboratory to the clinic is approaching
  202. Involvement of Stat1 in the Phagocytosis ofM. avium
  203. Red Blood Cells as Magnetic Carriers for MPI Applications
  204. Corrigendum: Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  205. Genetic Activation of the MET Pathway and Prognosis of Patients With High-Risk, Radically Resected Gastric Cancer
  206. Application of the standard addition method for the absolute quantification of neutral lipids in microalgae using Nile red
  207. Binding force measurement of NF-κB–ODNs interaction: An AFM based decoy and drug testing tool
  208. Modulation of Th1/Th2 immune responses to HIV-1 Tat by new pro-GSH molecules
  209. Immunophilin-loaded erythrocytes as a new delivery strategy for immunosuppressive drugs
  210. Redox Regulation of the Influenza Hemagglutinin Maturation Process: A New Cell-Mediated Strategy for Anti-Influenza Therapy
  211. Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms
  212. Dexamethasone restrains ongoing expression of interleukin-23p19 in peripheral blood-derived human macrophages
  213. Drug delivery by red blood cells
  214. Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer
  215. A practical and expeditious method for the preparation of the potential anticancer agent 5,6,11,12,17,18,23,24-octahydrocyclododeca[1,2-b:4,5-b′:7,8-b″:10,11-b‴]tetraindole (CTet)
  216. Cetuximab plus irinotecan after irinotecan failure in elderly metastatic colorectal cancer patients: Clinical outcome according to KRAS and BRAF mutational status
  217. Development of an oligonucleotide microarray for the detection and monitoring of marine dinoflagellates
  218. Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents
  219. The indole-3-carbinol cyclic tetrameric derivative CTet inhibits cell proliferation via overexpression of p21/CDKN1A in both estrogen receptor-positive and triple-negative breast cancer cell lines
  220. Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients
  221. Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy
  222. The increase in intra-macrophage thiols induced by new pro-GSH molecules directs the Th1 skewing in ovalbumin immunized mice
  223. Electrical characterization of DNA-functionalized solid state nanopores for bio-sensing
  224. Human erythrocytes as nanoparticle carriers for magnetic particle imaging
  225. Improved cellular uptake of functionalized single-walled carbon nanotubes
  226. Host genetic variants in the IGF binding protein-3 impact on survival of patients with advanced gastric cancer treated with palliative chemotherapy
  227. Autoantibodies Against the Exocrine Pancreas in Autoimmune Pancreatitis: Gene and Protein Expression Profiling and Immunoassays Identify Pancreatic Enzymes as a Major Target of the Inflammatory Process
  228. Effect of the redox state on HIV-1 tat protein multimerization and cell internalization and trafficking
  229. A multiplex magnetic capture hybridisation and multiplex Real-Time PCR protocol for pathogen detection in seafood
  230. Label-free quantification of activated NF-κB in biological samples by atomic force microscopy
  231. Synthesis and Biological Evaluation of a γ-Cyclodextrin-based Formulation of the Anticancer Agent 5,6,11,12,17,18,23,24- Octahydrocyclododeca[1,2-b:4,5-b’:7,8-b’’:10,11-b’’’]tetraindole (CTet)
  232. Oxidized Ultrashort Nanotubes as Carbon Scaffolds for the Construction of Cell-Penetrating NF-κB Decoy Molecules
  233. Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan
  234. Molecular Predictors of Efficacy to Anti-EGFR Agents in Colorectal Cancer Patients
  235. The preventive phase I trial with the HIV-1 Tat-based vaccine
  236. A potent enhancer element in the 5′-UTR intron is crucial for transcriptional regulation of the human ubiquitin C gene
  237. Parallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate
  238. A new platform for Real-Time PCR detection of Salmonella spp., Listeria monocytogenes and Escherichia coli O157 in milk
  239. Expression and characterization of the periplasmic cobalamin-binding protein ofPhotobacterium damselaesubsp.piscicida
  240. NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population
  241. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity
  242. Development of a multiplex PCR assay forPhotobacterium damselaesubsp.piscicidaidentification in fish samples
  243. HIV-infected long-term nonprogressors display a unique correlative pattern between the interleukin-7/interleukin-7 receptor circuit and T-cell homeostasis
  244. KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer
  245. PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer
  246. SIMULTANEOUS DIRECT DETECTION OFSALMONELLASPP.,LISTERIA MONOCYTOGENESANDESCHERICHIA COLIO157 IN MILK SAMPLES BY MAGNETIC EXTRACTION AND MULTIPLEX PCR
  247. Expression, Purification, and Characterization of the Recombinant Putative Periplasmic Hemin-Binding Protein (HutB) ofPhotobacterium damselaesubsp.piscicida
  248. De-ubiquitylation is the most critical step in the ubiquitin-mediated homeostatic control of the NF-κB/IKK basal activity
  249. Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up
  250. Erythrocytes as carriers of antisense PNA addressed against HIV-1gag-poltransframe domain
  251. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria
  252. Analysis of rRNA gene content in the Mediterranean dinoflagellate Alexandrium catenella and Alexandrium taylori: implications for the quantitative real-time PCR-based monitoring methods
  253. HIV-1 Tat Addresses Dendritic Cells to Induce a Predominant Th1-Type Adaptive Immune Response That Appears Prevalent in the Asymptomatic Stage of Infection
  254. Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS)
  255. GSH and analogs in antiviral therapy
  256. High resolution melting (HRM) analysis for the detection of ER22/23EK, BclI, and N363S polymorphisms of the glucocorticoid receptor gene
  257. Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer
  258. High Concordance of KRAS Status Between Primary Colorectal Tumors and Related Metastatic Sites: Implications for Clinical Practice
  259. Observation of Erythrocyte Dynamics in the Retinal Capillaries and Choriocapillaris Using ICG-Loaded Erythrocyte Ghost Cells
  260. The therapeutic phase I trial of the recombinant native HIV-1 Tat protein
  261. VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
  262. Erythrocyte-Mediated Delivery of Dexamethasone in Patients With Mild-to-Moderate Ulcerative Colitis, Refractory to Mesalamine: A Randomized, Controlled Study
  263. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in gastric cancer of intestinal and diffuse histotypes
  264. Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
  265. Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
  266. Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells
  267. Selective Killing ofMycobacterium avium–Infected Macrophages by Inhibition of Phosphorylated Signal Transducer and Activator of Transcription Type 1
  268. A novel diffuse gastric cancer susceptibility variant in E-cadherin (CDH1) intron 2: A case control study in an Italian population
  269. New Biomimetic Constructs for Improved In Vivo Circulation of Superparamagnetic Nanoparticles
  270. Pharmacogenetic Profiling for Cetuximab Plus Irinotecan Therapy in Patients With Refractory Advanced Colorectal Cancer
  271. Endogastric capsule for E-cadherin gene (CDH1) promoter hypermethylation assessment in DNA from gastric juice of diffuse gastric cancer patients
  272. Prolonged Islet Allograft Survival in Diabetic Mice Upon Macrophage Depletion by Clodronate-Loaded Erythrocytes
  273. A three-year longitudinal study on the effects of a diet containing genetically modified Bt176 maize on the health status and performance of sheep
  274. Inhibition of murine AIDS by pro-glutathione (GSH) molecules
  275. Cell-based drug delivery
  276. Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR
  277. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Lamivudine and Tenofovir
  278. Fast and sensitive quantitative detection of HIV DNA in whole blood leucocytes by SYBR green I real-time PCR assay
  279. Candidate HIV-1 gp140ΔV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge
  280. Detection of Listeria monocytogenes using a commercial PCR kit and different DNA extraction methods
  281. Loss of pericentromeric DNA methylation pattern in human glioblastoma is associated with altered DNA methyltransferases expression and involves the stem cell compartment
  282. Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapy
  283. Genotyping OLR1 Gene: A Genomic Biomarker for Cardiovascular Diseases
  284. Immunization with HIV protease peptides linked to syngeneic erythrocytes
  285. Long-term Treatment With Autologous Red Blood Cells Loaded With Dexamethasone 21–Phosphate in Pediatric Patients Affected by Steroid-dependent Crohn Disease
  286. Pharmacogenetic Profiling in Patients With Advanced Colorectal Cancer Treated With First-Line FOLFOX-4 Chemotherapy
  287. Current molecular techniques for the detection of microbial pathogens
  288. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
  289. High throughput HPLC-ESI-MS method for the quantitation of dexamethasone in blood plasma
  290. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer
  291. Candidate HIV-1 Tat vaccine development: from basic science to clinical trials
  292. Administration of Fludarabine-Loaded Autologous Red Blood Cells in Simian Immunodeficiency Virus-Infected Sooty Mangabeys Depletes pSTAT-1-Expressing Macrophages and Delays the Rebound of Viremia after Suspension of Antiretroviral Therapy
  293. Erythrocytes as a controlled drug delivery system: Clinical evidences
  294. Fludarabine delivery by autologous red blood cells induces macrophage depletion in chronically SIV-infected Sooty Mangabeys
  295. Monitoring of HAB species in the Mediterranean Sea through molecular methods
  296. A combination of diagnostic tools for rapid screening of ovine listeriosis
  297. Monitoring ofAlexandriumspecies in the Mediterranean Sea using a combined filter system–PCR assay detection method
  298. Immune response and protection by DNA vaccines expressing antigen 85B ofMycobacterium tuberculosis
  299. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
  300. The Use of Magnetic Nanoparticles in the Development of New Molecular Detection Systems
  301. Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples
  302. Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
  303. Pharmacogenetic Profiling and Clinical Outcome of Patients With Advanced Gastric Cancer Treated With Palliative Chemotherapy
  304. In Vitro Inhibition of Promyelocytic Leukemia/Retinoic Acid Receptor-α (PML/RARα) Expression and Leukemogenic Activity by DNA/LNA Chimeric Antisense Oligos
  305. Periodic Treatment with Autologous Erythrocytes Loaded with Dexamethasone 21-Phosphate for Fistulizing Pediatric Crohn's Disease
  306. Development of a magnetic capture hybridization-PCR assay for Listeria monocytogenes direct detection in milk samples
  307. Perturbations of Cell Cycle Control in T Cells Contribute to the Different Outcomes of Simian Immunodeficiency Virus Infection in Rhesus Macaques and Sooty Mangabeys
  308. Development of a qualitative PCR method for the Alexandrium spp. (Dinophyceae) detection in contaminated mussels (Mytilus galloprovincialis)
  309. Vaccines based on the native HIV Tat protein and on the combination of Tat and the structural HIV protein variant ΔV2 Env
  310. Methylenetetrahydrofolate reductase 677C/T gene polymorphism, gastric cancer susceptibility and genomic DNA hypomethylation in an at-risk Italian population
  311. Erythrocytes-Mediated Delivery of Dexamethasone in Steroid-Dependent IBD Patients-A Pilot Uncontrolled Study
  312. Interleukin 1B gene (IL-1B) and interleukin 1 receptor antagonist gene (IL-1RN) polymorphisms in Helicobacter pylori-negative gastric cancer of intestinal and diffuse histotype
  313. Mechanisms of Action and Antiproliferative Properties of Brassica oleracea Juice in Human Breast Cancer Cell Lines
  314. Prognostic Role of Thymidylate Synthase Polymorphisms in Gastric Cancer Patients Treated with Surgery and Adjuvant Chemotherapy
  315. Development of new procedures for the isolation of phytoplankton DNA from fixed samples
  316. Prognostic Role of Interleukin-1β Gene and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients With Advanced Gastric Cancer
  317. Erythrocyte-based drug delivery
  318. Loss of CD127 Expression Defines an Expansion of Effector CD8+T Cells in HIV-Infected Individuals
  319. Macrophage depletion induced by clodronate-loaded erythrocytes
  320. Targeting Nucleotide Dimers Containing Antiviral Nucleosides
  321. Bovine hexokinase type I: Full-length cDNA sequence and characterisation of the recombinant enzyme
  322. Editorial
  323. Locked Nucleic Acids (LNA): Versatile Tools for Designing Oligonucleotide Decoys with High Stability and Affinity
  324. Direct detection of Listeria monocytogenes from milk by magnetic based DNA isolation and PCR
  325. Development of a Real-Time PCR Assay Using SYBR Green I for Provirus Load Quantification in a Murine Model of AIDS
  326. Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application
  327. Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients
  328. Prognostic Analysis of E-Cadherin Gene Promoter Hypermethylation in Patients with Surgically Resected, Node-Positive, Diffuse Gastric Cancer
  329. Purification and characterization of a recombinant listeriolysin O expressed in Escherichia coli and possible diagnostic applications
  330. Transcription factor decoy oligonucleotides modified with locked nucleic acids: an in vitro study to reconcile biostability with binding affinity
  331. Effect of listeriolysin O-loaded erythrocytes on Mycobacterium avium replication within macrophages
  332. Combined analysis of E-cadherin gene (CDH1) promoter hypermethylation and E-cadherin protein expression in patients with gastric cancer: implications for treatment with demethylating drugs
  333. Development of a Real-Time PCR Assay for Rapid Detection and Quantification of Alexandrium minutum (a Dinoflagellate)
  334. Downregulation of nitric oxide formation by cytosolic phospholipase A2-released arachidonic acid
  335. Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients
  336. Predictive and Prognostic Role of E-Cadherin Protein Expression in Patients with Advanced Gastric Carcinomas Treated with Palliative Chemotherapy
  337. Association of thymidylate synthase polymorphisms with gastric cancer susceptibility
  338. Biochemical characterization of two GALK1 mutations in patients with galactokinase deficiency
  339. Drug Delivery through Phagocytosis of Red Blood Cells
  340. Specific Changes in the Posttranslational Regulation of Nucleolin in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  341. Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression
  342. Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections
  343. A new one-step RT-PCR method for virus quantitation in murine AIDS
  344. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge
  345. Screening E-Cadherin Germline Mutations in Italian Patients with Familial Diffuse Gastric Cancer: An Analysis in the District of Urbino, Region Marche, Central Italy
  346. High-level expression of the Listeria monocytogenes listeriolysin O in Escherichia coli and preliminary characterization of the purified protein
  347. Marine diatom growth on different forms of particulate silica: evidence of cell/particle interaction
  348. The G/A Nucleotide Change at cDNA Position 2494 in the E-Cadherin Gene (CDH1): Analysis in Italian Patients
  349. Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model
  350. Seasonal Blooms of the HAB Dinoflagellate Alexandrium taylori Balech in a New Mediterranean Area (Vulcano, Aeolian Islands)
  351. Association of CDH1 haplotypes with susceptibility to sporadic diffuse gastric cancer
  352. Inhibition of murine AIDS by a heterodinucleotide of azidothymidine and 9-(R)-2-(phosphonomethoxypropyl)adenine
  353. Repeated Cycles of Alternate Administration of Fludarabine and Zidovudine Plus Didanosine Inhibits Murine AIDS and Reduces Proviral DNA Content in Lymph Nodes to Undetectable Levels
  354. HIV-1 Tat-Based Vaccines: From Basic Science to Clinical Trials
  355. Inhibition of Macrophage iNOS by Selective Targeting of Antisense PNA†
  356. Design and characterization of decoy oligonucleotides containing locked nucleic acids
  357. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides
  358. Exogenous Interleukin-2 Administration Corrects the Cell Cycle Perturbation of Lymphocytes from Human Immunodeficiency Virus-Infected Individuals
  359. Modulation of ICAM-1 Expression in ECV304 Cells by Macrophage-Released Cytokines
  360. The potency of acyclovir can be markedly different in different cell types
  361. Inhibition of Proteasome Activity Strongly Affects Kiwifruit Pollen Germination. Involvement of the Ubiquitin/Proteasome Pathway as a Major Regulator
  362. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus
  363. Inhibition of HIV-1 Replication in Macrophages by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and 9-(R)-2-(Phosphono Methoxypropyl)adenine
  364. Identification of Blood Erythroid Markers Useful in Revealing Erythropoietin Abuse in Athletes
  365. Abnormal intracellular kinetics of cell-cycle-dependent proteins in lymphocytes from patients infected with human immunodeficiency virus: a novel biologic link between immune activation, accelerated T-cell turnover, and high levels of apoptosis
  366. Antioxidant capacity of extra-virgin olive oils
  367. New drug combinations for the treatment of murine AIDS and macrophage protection
  368. Identification of the main ubiquitination site in human erythroid α-spectrin
  369. The Ubiquitin-Dependent Proteolytic System and other Potential Targets for the Modulation of Nuclear Factor-kB (NF-kB)
  370. A new acyclic heterodinucleotide active against Human Immunodeficiency Virus and Herpes Simplex Virus
  371. Structure of the 5′ region of the human hexokinase type I (HKI) gene and identification of an additional testis-specific HKI mRNA
  372. Ubiquitin/proteasome system
  373. Selective Inhibition of NF-kB Activation and TNF-α Production in Macrophages by Red Blood Cell-Mediated Delivery of Dexamethasone
  374. Identification of ubiquitinated repeats in human erythroid α-spectrin
  375. Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate
  376. New Treatment Protocol Including Lympholytic and Antiretroviral Drugs to Inhibit Murine AIDS
  377. Metabolism, mitochondrial uptake and toxicity of 2′,3′-dideoxycytidine
  378. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme–membrane association control
  379. Influence of nutrient ratios on the in vitro extracellular polysaccharide production by marine diatoms from the Adriatic Sea
  380. Unscheduled cyclin B expression and p34 cdc2 activation in T lymphocytes from HIV-infected patients
  381. MONITORING ERYTHROPOIETIN ABUSE IN ATHLETES
  382. Activation of the ubiquitin proteolytic system in murine acquired immunodeficiency syndrome affects IkappaBalpha turnover
  383. IDENTIFICATION OF ALEXANDRIUM (DINOPHYCEAE) SPECIES USING PCR AND rDNA-TARGETED PROBES
  384. Alteration of α-spectrin ubiquitination due to age-dependent changes in the erythrocyte membrane
  385. Protein Degradation and Apoptotic Death in Lymphocytes during Fiv Infection: Activation of the Ubiquitin–Proteasome Proteolytic System
  386. Liposomes as carriers of the antiretroviral agent dideoxycytidine-5′-triphosphate
  387. Synthesis and Biological Application of a New Heterodinucleotide with Both Anti-HSV and Anti-HIV Activity
  388. cDNA Sequence of the Human Erythroid -Spectrin: Identification of a Base Deletion in the Sequence Database
  389. Efficient inhibition of macrophage TNF-α production upon targeted delivery of K48R ubiquitin
  390. Heterodimer-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiviral Drug Azidothymidine and the Antimycobacterial Drug Ethambutol
  391. Expression, Purification, and Characterization of a Recombinant Erythroid-Specific Hexokinase Isozyme
  392. Competitive PCR for Quantification of BM5d Proviral DNA in Mice with AIDS
  393. Drug delivery and targeting system
  394. Structure of the human hexokinase type I gene and nucleotide sequence of the 5′ flanking region
  395. Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir
  396. AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Homologous Erythrocytes as a Delivery System for Preferential Immunization with Putative Protective Antigens
  397. Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide
  398. Structure and expression of the human ubiquitin fusion–degradation gene (UFD1L)
  399. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  400. An Erythroid-Specific Exon Is Present in the Human Hexokinase Gene
  401. Expression of hexokinase mRNA in human hippocampus
  402. Use of Nonvolatile Buffers in Liquid Chromatography/Mass Spectrometry:  Advantages of Capillary-Scale Particle Beam Interfacing
  403. Antiretroviral Effect of Combined Zidovudine and Reduced Glutathione Therapy in Murine AIDS
  404. Oxidative Protein Damage and Degradation in Lymphocytes from Patients Infected with Human Immunodeficiency Virus
  405. Ubiquitin conjugation to endogenous proteins in the dormant tuber of Helianthus tuberosus and during the first cell cycle
  406. 2′,3′-Dideoxycytidine cytotoxicity in human macrophages
  407. Targeting antiviral nucleotide analogues to macrophages
  408. Up-Regulation of the Ubiquitin-Conjugating and Proteolytic Systems in Murine Acquired Immunodeficiency Syndrome
  409. Molecular bases of hexokinase deficiency
  410. The Inhibitory Effect of ddC on Human Immunodeficiency Virus Replication Diminishes in Cells that are Chronically Exposed to the Drug
  411. Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice
  412. Structural determinants that make hexokinase susceptible to ubiquitin-and ATP- dependent proteolysis
  413. Structure of the human hexokinase type I gene
  414. Identification of α-Spectrin Domains Susceptible to Ubiquitination
  415. Increased microbicidal activity of human monoblastoid cells upon long-term exposure to dideoxycytidine
  416. Encapsulation, metabolism and release of 2-fluoro-ara-AMP from human erythrocytes
  417. Inhibition of Murine AIDS by Reduced Glutathione
  418. Inhibition of Murine AIDS by Combination of AZT and Dideoxycytidine 5'-Triphosphate
  419. MODULATION OF THE HEAT SHOCK UBIQUITIN POOL IN SKELETONEMA COSTATUM (BACILLARIOPHYCEAE)1
  420. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.
  421. Azidothymidine Homodinucleotide-Loaded Erythrocytes as Bioreactors for Slow Delivery of the Antiretroviral Drug Azidothymidine
  422. High-Level Expression and Purification of a Human “Mini”-hexokinase
  423. Assignment of the hexokinase type 3 gene (HK3) to human chromosome band 5q35.3 by somatic cell hybrids and in situ hybridization
  424. Three new mutations (P183T, V150L, 528insG) and eleven sequence polymorphisms in Italian patients with galactose-1-phosphate uridyltransferase (GALT) deficiency
  425. Lactate catabolism by enzyme‐loaded red blood cells
  426. 2′,3′-Dideoxycytidine metabolism in a new drug-resistant cell line
  427. Inhibition of HIV-1 and LP-BM5 Replication in Macrophages by Dideoxycytidine and Dideoxycytidine 5′-Triphosphate
  428. Effect of Antiviral Treatments on the Bone Marrow in Murine AIDS
  429. 2′,3′-Dideoxycytidine induced drug resistance in human cells
  430. Efficacy and Toxicity of Long-Term Administration of 2′,3′-dideoxycytidine in the LP-BM5 Murine-Induced Immunodeficiency Model
  431. UBIQUITIN INSKELETONEMA COSTATUM
  432. FIV infection of macrophages: in vitro and in vivo inhibition by dideoxycytidine 5′-triphosphate
  433. Ubiquitin Is Conjugated to the Cytoskeletal Protein α-Spectrin in Mature Erythrocytes
  434. Hexokinase Mutations that Produce Nonspherocytic Hemolytic Anemia
  435. Effect of heat stress on polyamine content and protein pattern in Skeletonema costatum
  436. Modulated red blood cell survival by membrane protein clustering
  437. Red blood cells as a delivery system for AZT
  438. Targeting dexamethasone to macrophages
  439. Preparation and characterization of biotinylated red blood cells
  440. Feline Immunodeficiency Virus Infection of Macrophages:In Vitroandin VivoInhibition by Dideoxycytidine-5′-triphosphate-Loaded Erythrocytes
  441. Red blood cell phagocytosis following hexokinase inactivation
  442. Localization and age-dependent expression of hexokinase mRNA in the rat brain
  443. The soluble but not mitochondrially bound hexokinase is a substrate for the ATP- and ubiquitin-dependent proteolytic system
  444. HPLC Analysis of Taurine in Human Plasma Sample Using the Dabs-Ci Reagent with Sensitivity at Picomole Level
  445. The female longevity phenomenon. Hypotheses on some molecular and cell biology aspects
  446. Methanol detoxification by enzyme‐loaded erythrocytes
  447. Molecular analysis of G6PD variants in northern Italy: a study on the population from the Ferrara district
  448. Phagocytosis reduces HIV-1 production in human monocytes/macrophages infected in vitro
  449. Red Blood Cell Aging. Proceedings of a Symposium Held in Urbino, Italy, 24-26 September 1990.Mauro Magnani , Antonio De Flora
  450. The bone marrow in murine AIDS
  451. Direct observation of hexokinase translocation in stimulated macrophages
  452. Red blood cell age dependent modifications of inositol 1,4,5-trisphosphate
  453. Glucose-6-Phosphate Dehydrogenase Nucleotide 1311 Polymorphism in Central Italy (Marche Region)
  454. Intracellular distribution of hexokinase in rabbit brain
  455. In vitro and in vivo toxicity of 2′,3′-dideoxycytidine in mice
  456. Intracellular Distribution of Protein as a Determinant for Ubiquitination and Proteolytic Degradation
  457. Red blood cells as an antigen‐delivery system
  458. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.
  459. A recombinant human ‘mini’-hexokinase is catalytically active and regulated by hexose 6-phosphates
  460. In vitro targeting of erythrocytes to cytotoxic T‐cells by coupling of Thy‐1.2 monoclonal antibody
  461. Increased glucose metabolism by enzyme‐loaded erythrocytes in vitro and in vivo normalization of hyperglycemia in diabetic mice
  462. Acetaldehyde Oxidation by Aldehyde Dehydrogenase Loaded Erythrocytes
  463. Analysis of amino acids as DABS-derivatives with a sensitivity to the femtomole level using RP-HPLC narrow-bore columns
  464. Comparison of Uricase-Bound and Uricase-Loaded Erythrocytes as Bioreactors for Uric Acid Degradation
  465. Normalization of Hyperglycemia in Diabetic Mice by Enzyme-Loaded Erythrocytes
  466. Red Blood Cells as Advanced Drug Delivery Systems for Antiviral Nucleoside Analogues
  467. Xenobiotic Detoxification by GSH-Loaded Erythrocytes
  468. The Use of Resealed Erythrocytes as Carriers and Bioreactors
  469. Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli
  470. Human red blood cells as bioreactors for the inactivation of harmful xenobiotics
  471. Cell age dependent decay of human erythrocytes glutathione S-transferase
  472. Red Blood Cell Aging
  473. Free Radicals Promote “In Vitro” a Different Intracellular Decay of Rabbit Reticulocyte and Erythrocyte Glycolytic Enzymes
  474. Glucose-6-Phosphate Dehydrogenase Lodi^844C: A Study on Its Expression in Blood Cells and Muscle
  475. In vitro toxicity and metabolism of 2′,3′-dideoxycytidine, an inhibitor of human immunodeficiency virus infectivity
  476. Role and Mechanism of Hexokinase Decay During Reticulocyte Maturation and Cell Aging
  477. Immunological quantification of human hexokinase type I
  478. A nonlinear three-compartiment model for the administration of 2′,3′-dideoxycytidine by using red blood cells as bioreactors
  479. Preparation and characterization of monoclonal antibodies to human hexokinase type I
  480. Hexokinase: one gene or two [letter; comment]
  481. ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts
  482. Similarities and differences between human and rat hexokinases type I
  483. IN VIVO ACCELERATED ACETALDEHYDE METABOLISM USING ACETALDEHYDE DEHYDROGENASE-LOADED ERYTHROCYTES
  484. Acetaldehyde Dehydrogenase-Loaded Erythrocytes as Bioreactors for the Removal of Blood Acetaldehyde
  485. Cell age dependent decay of human erythrocytes glucose-6-phosphate isomerase
  486. Human red blood cells as bioreactors for the release of 2′,3′-dideoxycytidine, an inhibitor of HIV infectivity
  487. Improved stability of 2,3‐bisphosphoglycerate during storage of hexokinase‐overloaded erythrocytes
  488. Reversed-phase high-performance liquid chromatography separation of dimethylaminoazobenzene sulfonyl- and dimethylaminoazobenzene thiohydantoin-amino acid derivatives for amino acid analysis and microsequencing studies at the picomole level
  489. Effects of Ca2+ and lipoxygenase inhibitors on hexokinase degradation in rabbit reticulocytes
  490. Human Red Blood Cell Loading with Hexokinase-Inactivating Antibodies
  491. Reversed-phase liquid chromatographic determination of 2′,3′-dideoxycytidine in human blood samples
  492. Improved metabolic properties of hexokinase-overloaded human erythrocytes
  493. Hexokinase type I multiplicity in human erythrocytes
  494. Role of hexokinase in the regulation of erythrocyte hexose monophosphate pathway under oxidative stress
  495. Effect of phenylhydrazine on red blood cell metabolism
  496. Simultaneous Preparation from Human Placenta of Several Enzymes of Glucose Metabolism
  497. Superoxide anions are required for the inactivation ofEscherichia coli induced by high concentrations of hydrogen peroxide
  498. Hexokinase microheterogeneity in rabbit red blood cells and its behaviour during reticulocytes maturation
  499. Effect of age on some properties of mice erythrocytes
  500. Membrane-Bound Immunoglobulins Increase during Red Blood Cell Aging
  501. Purification, properties, and evidence for two subtypes of human placenta hexokinase type I
  502. The interaction of phosphorylated sugars with human hexokinase I
  503. Adenine and pyridine nucleotides during rabbit reticulocyte maturation and cell aging
  504. Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine
  505. Relationships between the age-dependent decay of glucose-1,6-bisphosphate synthesis, phosphoribomutase and phosphoglucomutase in human red cells
  506. Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency
  507. First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency
  508. Human erythrocyte hexokinases are immunologically related
  509. Rat red blood cell hexokinase purification, properties and age-dependence
  510. Increased Erythrocyte Adenosine Deaminase Activity without Haemolytic Anaemia
  511. Redox and Energetic State of Red Blood Cells in G6PD Deficiency, Heterozygous β-Thalassemia and the Combination of Both
  512. Complete high-performance liquid chromatographic separation of 4-N,N-dimethylaminoazobenzene-4′-thiohydantoin and 4-dimethylaminoazobenzene-4′-sulphonyl chloride amino acids utilizing the same reversed-phase column at room temperature
  513. Hereditary nonspherocytic hemolytic anemia due to a new hexokinase variant with reduced stability
  514. Human erythrocyte hexokinase deficiency: a new variant with abnormal kinetic properties
  515. Hexokinase in human chorionic villi
  516. Regulatory properties of human erythrocyte hexokinase during cell ageing
  517. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells
  518. Red blood cell adenine nucleotides abnormalities in down syndrome
  519. Hexokinase in developing rabbit erythroid cells
  520. A new direct radioassay for the determination of true erythrocyte hexokinase activity
  521. Relationship between the rate of erythrocyte hexose monophosphate pathway and the glucose 6-phosphate concentration
  522. Rabbit red blood cell hexokinase:intracellular distribution during reticulocytes maturation
  523. Regulatory properties of rabbit red blood cell hexokinase at conditions close to physiological
  524. Increased Activity of Glutathione S-Transferase and Fast Decay of Reduced Glutathione in Fanconi’s Anemia Erythrocytes
  525. Rabbit red blood cell hexokinase
  526. Red Blood Cell Hexokinase in Fanconi’s Anemia
  527. Regional Mapping of Hexokinase-1 within the Short Arm of Chromosome 10
  528. Pig red blood cell hexokinase: Evidence for the presence of hexokinase types II and III, and their purification and characterization
  529. Pig red blood cell hexokinase: Regulatory characteristics and possible physiological role
  530. Prenatal prediction of duplication 10q24→qter by gene dosage of GOT1 on uncultured amniotic cells
  531. The age-dependent metabolic decline of the red blood cell
  532. Red Blood Cell Hexokinase in Tumor Bearing Mice
  533. Red blood cell glucose metabolism in trisomy 10p: possible role of hexokinase in the erythrocyte
  534. Relationship between Erythrocyte Hexokinase in Cancer Patients and Red Cell Age
  535. Red Blood Cell Galactokinase Activity and Presenile Cataracts
  536. Regional mapping of the locus for hexokinase-1 (HK1)
  537. Molecular forms of red blood cell hexokinase
  538. Solubilization, purification, and properties of rabbit brain hexokinase
  539. Adult and fetal galactokinases in human red blood cells
  540. Chromatographic fractionation of multiple forms of red blood cell hexokinase
  541. Cell survival and glutathione reductase
  542. A New Variant of Galactokinase
  543. [1] Hexokinase from rabbit red blood cells
  544. Human Erythrocyte Galactokinase: A Population Survey
  545. Expression of GALT in two unrelated 9p- patients. Evidence for assignment of the GALT locus to the 9p21 band
  546. The possibility of prenatal diagnosis by gene dosage: Confirmation of duplication 10q24→qter from Got-l activity in fetal erythrocytes
  547. Hexokinase isozymic pattern during red cell aging
  548. Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase
  549. Galactokinase activity and red blood cell age
  550. Studies on the use of Sepharose-N-Aminohexanoyl-Glucosamine for purification of rabbit red blood cell hexokinase
  551. Spectrophotometric analysis of interferences due to polyols in the assay of protein by Lowry's method
  552. Comparative studies of glucose metabolism on mammals' red blood cells
  553. Decay pattern of rabbit erythrocyte hexokinase in cell aging
  554. Comparative studies of galactokinase activity on mammal's red blood cells
  555. Confirmation of regional assignment of nucleoside phosphorylase to band 14q13 by gene-dosage studies
  556. Comparative studies on red blood cell glucose phosphorylating activities of mammals
  557. Glucokinase and Hexokinase in Pig Erythrocytes
  558. Relationship between glucose phosphorylating activities and erythrocyte age
  559. Immobilization of Enzymes and Proteins on Red Blood Cells
  560. An Ex Vivo Erythrocyte Model for Investigating Oxidative Metabolism